Advanced Glycation end Products, Oxidative Stress and Diabetic Nephropathy

Abstract

About 246 million people worldwide had diabetes in 2007. The global figure of people with diabetes is projected to increase to 370 million in 2030. As the prevalence of diabetes has risen to epidemic proportions worldwide, diabetic nephropathy has become one of the most challenging health problems. Therapeutic options such as strict blood glucose and blood pressure controls are effective for preventing diabetic nephropathy, but are far from satisfactory, and the number of diabetic patients on end‐stage renal disease is still increasing. Therefore, a novel therapeutic strategy that could halt the progression of diabetic nephropathy should be developed. There is accumulating evidence that advanced glycation end products (AGEs), senescent macroprotein derivatives formed at an accelerated rate under diabetes, play a role in diabetic nephropathy via oxidative stress generation. In this paper, we review the pathophysiological role of AGEs and their receptor (RAGE)‐oxidative stress system in diabetic nephropathy.

Cited by papers we hold 8

• Glabridin, a bioactive component of licorice, ameliorates diabetic nephropathy by regulating ferroptosis and the VEGF/Akt/ERK pathways · 2022
  No notice
• Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment · 2021
  No notice
• Activation of Notch1 signaling in podocytes by glucose-derived AGEs contributes to proteinuria · 2020
  Not checked
• Exploiting Common Aspects of Obesity and Alzheimer’s Disease · 2020
  Not checked
• Pathophysiology of Type 2 Diabetes Mellitus · 2020
  No notice
• Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury · 2018
  No notice
• Diabetic Nephropathy: a Tangled Web to Unweave · 2017
  No notice
• Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.